• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Editorial: Advanced therapeutic strategies and safety profiles in heart failure with reduced ejection fraction: contextualizing recent findings.社论：射血分数降低的心力衰竭的先进治疗策略和安全性概况：解读近期研究结果
Front Pharmacol. 2025 Apr 28;16:1607362. doi: 10.3389/fphar.2025.1607362. eCollection 2025.
2
Comparison of Blood Volume Profiles in Heart Failure With Preserved and Reduced Ejection Fractions: Sex Makes a Difference.比较射血分数保留型和降低型心力衰竭患者的血容量特征：性别有差异。
Circ Heart Fail. 2024 Jun;17(6):e010906. doi: 10.1161/CIRCHEARTFAILURE.123.010906. Epub 2024 Jun 6.
3
Current treatment of heart failure with preserved ejection fraction: should we add life to the remaining years or add years to the remaining life?射血分数保留的心力衰竭的当前治疗：我们应该为剩余岁月增添生命，还是为剩余生命增添岁月？
Cardiol Res Pract. 2013;2013:130724. doi: 10.1155/2013/130724. Epub 2013 Oct 24.
4
Genetic architecture of heart failure with preserved versus reduced ejection fraction.保留射血分数与降低射血分数心力衰竭的遗传结构。
Nat Commun. 2022 Dec 14;13(1):7753. doi: 10.1038/s41467-022-35323-0.
5
Current Insights and Future Directions in the Treatment of Heart Failure with Preserved Ejection Fraction.射血分数保留的心力衰竭治疗的现状与展望。
Int J Mol Sci. 2023 Dec 28;25(1):440. doi: 10.3390/ijms25010440.
6
Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure.保留的右心室射血分数可预测晚期心力衰竭患者的运动能力和生存率。
J Am Coll Cardiol. 1995 Apr;25(5):1143-53. doi: 10.1016/0735-1097(94)00511-n.
7
Heart Failure With Preserved Ejection Fraction (HFpEF)射血分数保留的心力衰竭（HFpEF）
8
Clinical Update in Heart Failure with Preserved Ejection Fraction.射血分数保留的心力衰竭的临床更新。
Curr Heart Fail Rep. 2024 Oct;21(5):461-484. doi: 10.1007/s11897-024-00679-5. Epub 2024 Sep 3.
9
Cost-effectiveness of Dapagliflozin for the Treatment of Heart Failure With Reduced Ejection Fraction.达格列净治疗射血分数降低的心力衰竭的成本效益分析。
JAMA Netw Open. 2021 Jul 1;4(7):e2114501. doi: 10.1001/jamanetworkopen.2021.14501.
10
Risk stratification in heart failure with mild reduced ejection fraction.心力衰竭伴轻度射血分数降低的风险分层。
Eur J Prev Cardiol. 2020 Dec;27(2_suppl):59-64. doi: 10.1177/2047487320951104.

本文引用的文献

1
2024 update in heart failure.2024年心力衰竭治疗进展
ESC Heart Fail. 2025 Feb;12(1):8-42. doi: 10.1002/ehf2.14857. Epub 2024 May 28.
2
Initiation and Up-titration of Guideline-directed Medical Therapy for Patients with Heart Failure: Better, Faster, Stronger!心力衰竭患者指南导向药物治疗的起始与剂量滴定：更优、更快、更强！
Card Fail Rev. 2024 Mar 6;10:e03. doi: 10.15420/cfr.2023.20. eCollection 2024.
3
2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee.2024年美国心脏病学会降低射血分数心力衰竭治疗专家共识决策路径：美国心脏病学会解决方案集监督委员会报告
J Am Coll Cardiol. 2024 Apr 16;83(15):1444-1488. doi: 10.1016/j.jacc.2023.12.024. Epub 2024 Mar 8.
4
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南：美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2022 May 3;145(18):e895-e1032. doi: 10.1161/CIR.0000000000001063. Epub 2022 Apr 1.
5
Blood Pressure and Safety Events With Vericiguat in the VICTORIA Trial.在 VICTORIA 试验中维立西呱与血压和安全性事件。
J Am Heart Assoc. 2021 Nov 16;10(22):e021094. doi: 10.1161/JAHA.121.021094. Epub 2021 Nov 6.
6
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.维立西呱治疗射血分数降低的心力衰竭患者的疗效。
N Engl J Med. 2020 May 14;382(20):1883-1893. doi: 10.1056/NEJMoa1915928. Epub 2020 Mar 28.
7
Drug-induced heart failure.药物性心力衰竭。
Am J Health Syst Pharm. 2011 Oct 1;68(19):1791-804. doi: 10.2146/ajhp100637.

Editorial: Advanced therapeutic strategies and safety profiles in heart failure with reduced ejection fraction: contextualizing recent findings.

作者信息

Asensio-Lopez Maria Del Carmen, Severino Paolo, Lax Antonio

机构信息

Cardiology Clinical & Experimental Group, Department of Medicine, Biomedical Research Institute (IMIB-Pascual Parrilla), University of Murcia, Murcia, Spain.

Department of Research (CSO), Biocardio SL, El Palmar, Murcia, Spain.

出版信息

Front Pharmacol. 2025 Apr 28;16:1607362. doi: 10.3389/fphar.2025.1607362. eCollection 2025.

DOI:10.3389/fphar.2025.1607362
PMID:40356986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12067795/
Abstract
摘要